Direct healthcare costs of Rome IV or Rome III ‐defined irritable bowel syndrome in the United Kingdom

Willingness to accept risk with medication in return for cure of symptoms among patients with Rome IV irritable bowel syndrome

(2022) Vivek C. Goodoory et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel Syndrome

(2021) Vivek C. Goodoory et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Natural History and Disease Impact of Rome IV versus Rome III Irritable Bowel Syndrome: A Longitudinal Follow-up Study.

(2021) Vivek C. Goodoory et al.   Clinical Gastroenterology and Hepatology

British Society of Gastroenterology guidelines on the management of irritable bowel syndrome

(2021) Dipesh H Vasant et al.   GUT

A Review of the Evidence and Recommendations on Communication Skills and the Patient–Provider Relationship: A Rome Foundation Working Team Report

(2021) Douglas A. Drossman et al.   GASTROENTEROLOGY

Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis

(2021) Christopher J. Black et al.   GUT

Long-Term Outcome of Multidisciplinary Versus Standard Gastroenterologist Care for Functional Gastrointestinal Disorders: A Randomized Trial

(2021) Chamara Basnayake et al.   Clinical Gastroenterology and Hepatology

Mortality Risk in Irritable Bowel Syndrome

(2020) Kyle Staller et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom

(2020) Olafur S. Palsson et al.   GASTROENTEROLOGY

Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis

(2020) Christopher J Black et al.   GUT

Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis

(2020) Priya Oka et al.   Lancet Gastroenterology & Hepatology

Standard gastroenterologist versus multidisciplinary treatment for functional gastrointestinal disorders (MANTRA): an open-label, single-centre, randomised controlled trial

(2020) Chamara Basnayake et al.   Lancet Gastroenterology & Hepatology

Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care

(2020) Christopher J Black et al.   GUT

Irritable bowel syndrome

(2020) Alexander C Ford et al.   LANCET

Racial disparity in healthcare utilization among patients with Irritable Bowel Syndrome: results from a multicenter cohort

(2020) Casey Silvernale et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis

(2019) Christopher J Black et al.   GUT

Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria

(2019) Christopher J. Black et al.   Clinical Gastroenterology and Hepatology

Efficacy of soluble fibre, antispasmodic drugs, and gut–brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis

(2019) Christopher J Black et al.   Lancet Gastroenterology & Hepatology

Work Productivity and Activity Impairment in Irritable Bowel Syndrome (IBS): A Multifaceted Problem

(2018) Åsa Frändemark et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis

(2018) Christopher J. Black et al.   GASTROENTEROLOGY

The economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countries

(2016) A. Lewis et al.   BMC HEALTH SERVICES RESEARCH

Bowel Disorders

(2016) Brian E. Lacy et al.   GASTROENTEROLOGY

Development and Validation of the Rome IV Diagnostic Questionnaire for Adults

(2016) Olafur S. Palsson et al.   GASTROENTEROLOGY

Economic burden of irritable bowel syndrome in China

(2016) Fang Zhang et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Calculating Total Health Service Utilisation and Costs from Routinely Collected Electronic Health Records Using the Example of Patients with Irritable Bowel Syndrome Before and After Their First Gastroenterology Appointment

(2015) Caroline Canavan et al.   PHARMACOECONOMICS

Irritable bowel syndrome in adults in primary care: summary of updated NICE guidance

(2015) C. Hookway et al.   BMJ-British Medical Journal

Irritable bowel syndrome in adults in primary care: summary of updated NICE guidance

(2015) C. Hookway et al.   BMJ-British Medical Journal

Review article: the economic impact of the irritable bowel syndrome

(2014) C. Canavan et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The Management of Irritable Bowel Syndrome (Ibs) in England: A Real World Study in Primary Care Clinical Practice

(2014) I. Caldwell et al.   VALUE IN HEALTH

Functional dyspepsia: the economic impact to patients

(2013) B. E. Lacy et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

2012 David Sun Lecture: Helping Your Patient by Helping Yourself—How to Improve the Patient–Physician Relationship by Optimizing Communication Skills

(2013) Douglas A Drossman   AMERICAN JOURNAL OF GASTROENTEROLOGY

A Positive Diagnostic Strategy Is Noninferior to a Strategy of Exclusion for Patients With Irritable Bowel Syndrome

(2013) Luise M. Begtrup et al.   Clinical Gastroenterology and Hepatology

Validation of the Rome III Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care

(2013) Alexander C. Ford et al.   GASTROENTEROLOGY

Effect of Dyspepsia on Survival: A Longitudinal 10-Year Follow-Up Study

(2012) Alexander C Ford et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The Patient Health Questionnaire 12 Somatic Symptom scale as a predictor of symptom severity and consulting behaviour in patients with irritable bowel syndrome and symptomatic diverticular disease

(2010) R. C. Spiller et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Is Irritable Bowel Syndrome a Diagnosis of Exclusion?: A Survey of Primary Care Providers, Gastroenterologists and IBS Experts

(2010) Brennan M R Spiegel et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

How does comorbidity affect cost of health care in patients with irritable bowel syndrome? A cohort study in general practice

(2010) Per A Johansson et al.   BMC GASTROENTEROLOGY

Estimation of primary care treatment costs and treatment efficacy for people with Type 1 and Type 2 diabetes in the United Kingdom from 1997 to 2007*

(2010) C. J. Currie et al.   DIABETIC MEDICINE

Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS

(2010) P. Jerndal et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Irritable Bowel Syndrome: A 10-Yr Natural History of Symptoms and Factors That Influence Consultation Behavior

(2008) Alexander C. Ford et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Optimal recall length in survey design

(2008) Philip M. Clarke et al.   JOURNAL OF HEALTH ECONOMICS